To date, a large body of evidence has suggested that estrogen-activated ERα favorably influences cardiomyocyte survival both in vivo and in vitro model systems [8], [40], [83]–[85], explaining the gender-dependent protection against atherosclerosis and cardiovascular disease [86]. This evidence concerns the gene ESR1 and cardiovascular disorder.